Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. A. & L. Schmidgall is an established Austrian pharmaceutical company specializing in the marketing, sales, and distribution of over-the-counter (OTC) medicines, medical devices, food supplements, and cosmetics. Founded in 1947, the company has built a strong presence in the Austrian pharmacy market with well-known proprietary and licensed brands such as Carmol, Osanit, Osa, and Bionect. In 2020, Dr. A. & L. Schmidgall was acquired by Verfora, a subsidiary of the Swiss healthcare group Galenica, allowing it to expand its distribution network and product portfolio. The company continues to operate as an independent entity in Vienna, providing comprehensive sales, marketing, and logistics services to pharmacies and wholesalers across Austria.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. A. & L. Schmidgall.